Since the beginning of the pandemic, hospitals have been treating and triaging an influx of COVID-19 patients. Hundreds of thousands of seriously ill patients have been hospitalized, with some having to stay and receive care for months at a time.   But now as some of those patients return home, hospitals are opening post-COVID clinics to help with their transition. Health care professionals are monitoring the recovery process and taking note of persisting health issues from the disease. Mafuzur Rahman, clinician and leader of the post-discharge COVID-19 clinic at SUNY Downstate in Brooklyn, New York, and Margaret Wheeler, a physician at the Richard Fine’s People Clinic at San Francisco General Hospital, talk about the health effects they have seen in their patients and what patients may need for recovery. A federal court in California recently vacated the three popular dicamba herbicides—Xtendimax, Fexipan, and Engenia—after the court determined the EPA violated the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) by registering the chemicals for use. Environmental advocates rejoiced, while farm groups lamented the decision as yet another hurdle for farmers to overcome during a difficult year. More herbicides could face legal challenges in the coming years. But they were once part of a golden era of U.S. agriculture, and a key player in the rise of modern industrialized growing systems. There are over 3,000 mosquitoes, but only a handful feast on blood, like the yellow fever mosquito, Aedes aegypti. Other mammals also have blood running through their veins, but are bit less frequently. So why do mosquitoes love humans so much? New research on these bugs look into the cause, investigating mosquitoes’ preference for certain mammal odors and human population densities. Another paper examines a potential gene solution to decrease mosquito bites—thus lowering transmission of mosquito-borne diseases. Joining Ira to talk about the latest research and more mosquito science is “Lindy” McBride, biology assistant professor at Princeton University and Jake Tu, biochemistry professor at Virginia Tech.